NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantation.
Immunotherapy., Mar;4(3):305-13 (2012)
Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7.
Blood., May;119(22):5164-72 (2012)
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.
Blood., Jun;119(24):5697-705 (2012)
Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy.
Immunity., Jan;20(1):107-18 (2004)
Granulocytic sarcoma presenting as pneumonia in a child with t(8;21) acute myelogenous leukemia: diagnosis by fluorescent in situ hybridization.
J. Pediatr. Hematol. Oncol., Jul;26(7):431-4 (2004)
C/EBPbeta suppression by interruption of CUGBP1 resulting from a complex rearrangement of MLL.
Cancer Genet. Cytogenet., Sep;177(2):108-14 (2007)
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.
Hum. Gene Ther., Apr;21(4):427-37 (2010)
Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.
Hum. Gene Ther., May;23(5):444-50 (2012)
Activated peripheral T lymphocytes undergo apoptosis when cultured with monocytes activated by HLA class II ligation.
Cell. Immunol., Oct;225(2):101-12 (2003)
Combining CD 19-redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies
A High Throughput Microelectroporation Device to Introduce a Chimeric Antigen Receptor to Redirect the Specificity of Human T cells
Biomedical Microdevices (Springer)
Acquisition, preparation, and functional assessment of human NK cells for adoptive immunotherapy
Methods in Molecular Biology
Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotype
piggyBac transposon/transposase system to generate CD19-specific T cells for treatment of B-lineage malignancies